Dean Y. Li - Oct 1, 2025 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Oct 1, 2025
Transactions value $
$0
Form type
4
Date filed
10/3/2025, 04:27 PM
Previous filing
Jul 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Li Dean Y Director C/O RECURSION PHARMACEUTICALS, 41 S. RIO GRANDE STREET, SALT LAKE CITY /s/ Jonathan Golightly, attorney-in-fact 2025-10-03 0001837016

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +1.96K +0.16% $0.00 1.24M Oct 1, 2025 Direct F1
holding RXRX Class A Common Stock 1.42M Oct 1, 2025 By Dean Y. Li Revocable Trust
holding RXRX Class A Common Stock 137K Oct 1, 2025 By Dean Y. Li GRAT
holding RXRX Class A Common Stock 421K Oct 1, 2025 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.